SCHEMBL9938199

SCHEMBL9938199

CN(C)CC(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
PRKCE Q02156 1/20 0.41
MAOA P21397 2/20 0.34
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NCEH1 Q6PIU2 1/20 0.33
HTR1A P08908 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
NLRP3 Q96P20 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23199823 0.99 PDGFRB (0.40) PDGFRBPDGFRAPRKCEMAOALMNA
SCHEMBL23199818 0.89 HTR1A (0.35) PDGFRBPDGFRAPRKCEMAOALMNA
SCHEMBL9938547 0.87 KDM4E (0.40) PDGFRBPDGFRAMAOALMNAL3MBTL1
SCHEMBL996026 0.83 CA12 (0.41) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL668901 0.83 CA12 (0.41) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL30645497 0.81 KMT2A (0.42) PDGFRBPDGFRAHTR1AHTR1BKDM4E
SCHEMBL9938274 0.80 ELANE (0.38) LMNAL3MBTL1HTR1DHTR1BALDH1A1
SCHEMBL9938614 0.80 MEN1 (0.42) HTR1DHTR1BKMT2A
SCHEMBL9938270 0.80 ACHE (0.40)
SCHEMBL19253296 0.79 NCEH1 (0.30) NCEH1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801553-A2 PRODRUGS OF FULVESTRANT Kashiv Biosciences, LLC (US) 2021-04-14 EP disclosed
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed